Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia - Still a Valid Treatment Option, or is the Game Over?
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab (FCR) has been established as the current standard of care for young and fit patients with chronic lymphocytic leukemia (CLL). In the early nineties of the last century, long before the advent of fludarabine or antibody-based strat...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Università Cattolica del Sacro Cuore
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507531/ |